e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Assessment of airway inflammation by exhaled gases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study
A. Malinovschi, A. Michils, S. Michiels, A. Van Muylem (Uppsala, Sweden; Brussels, Belgium)
Source:
Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Session:
Assessment of airway inflammation by exhaled gases
Session type:
Poster Discussion
Number:
3554
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Malinovschi, A. Michils, S. Michiels, A. Van Muylem (Uppsala, Sweden; Brussels, Belgium). Baseline exhaled NO in relation to asthma control improvement after increased dose of inhaled steroids – A real-life study. Eur Respir J 2013; 42: Suppl. 57, 3554
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Longitudinal changes in exhaled breath GC/MS profiles during loss of asthma control by prospective steroid withdrawal
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
The effects of oral care on FeNO measurement in asthmatic patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint: Results of the PACMAN2 study
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
A predictive model of failed stepping-down of inhaled corticosteroids in adult asthmatics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Effect of tiotropium on exhaled breath temperature in patients with COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Effects of inhaled steroid therapy on exhaled breath condensate and blood biomarkers in newly diagnosed smoker asthmatics
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Evaluating the effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Unbiased clustering of severe asthma patients based on exhaled breath profiles
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Does measuring pre or post bronchodilator FEV1 influence the level of asthma control in patients with controlled or partially controlled asthma as measured by GINA scale?
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
ΔFEF25-75 a surrogate marker for mild intermittent asthma: A poor man’s FeNO
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013
Suppression of
F
ENO
with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept